OncoSure Testing

Firefighters dedicate their careers to protecting others, but the impact of the job can extend beyond the call. Understanding occupational exposures and long-term health risks is an important part of proactive healthcare.

Know more about your health with OncoSure.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

Your health information should be easy to access. With the OncoSure Patient Portal, you can securely view your test results wherever you are, whenever they're available. It's one more way we're making the cancer screening experience more convenient from start to finish.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

Every career comes with unique challenges. For construction workers, certain workplace exposures may accumulate over years.

OncoSure is helping expand cancer screening options through blood-based multi-cancer screening designed to complement established screening methods.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

Every patient has a reason for getting screened. Whether it's family history, peace of mind, or encouragement from someone they love, every journey begins with a decision.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

Cancer affects millions of people each year, reinforcing the importance of continued innovation in cancer screening. OncoSure is proud to provide a blood-based multi-cancer screening platform designed to evaluate biomarkers associated with more than 200 cancer types.
-
-
-
-
-
-
-
-
-
-
-
-
OncoSure is intended to complement recommended cancer screening and is not a diagnostic test. Healthcare providers should interpret results alongside clinical evaluation.

Broad pharmacogenomic coverage starts with one comprehensive panel. The OncoSure PGx test includes medications across multiple therapeutic areas, delivering genetic insights that support informed medication management.
-
-
-
-
-
-
-
-
-
-
-

Cancer screening continues to evolve through advancements in laboratory science. OncoSure provides a blood-based multi-cancer screening platform designed to complement established screening methods through broad biomarker analysis.
-
-
-
-
-
-
-
-
-
-
-
-
v

Great to see multi-cancer blood testing becoming part of the national conversation. Increased awareness of MCED technologies is an important step toward improving early detection, and OncoSure is proud to be helping advance the future of blood-based cancer screening.

www.today.com

PGx testing goes beyond traditional genetic analysis by evaluating genetic factors associated with medication metabolism and drug response. At OncoSure, our PGx testing is designed to provide clinically relevant genetic insights that can support healthcare providers in medication management.
-
-
-
-
-
-
-
-
-
-
-
-